| Jan 2, 2022 | Jan 1, 2023 | Dec 31, 2023 |
---|
Revenue | - | 6 | 8 |
---|
Cost of revenue | - | 23 | 63 |
---|
Gross margin | - | -17 | -55 |
---|
Research and development | 38 | 58 | 88 |
---|
Selling, general and administrative | 30 | 52 | 79 |
---|
Impairment of equipment | - | 5 | 4 |
---|
Total operating expenses | 70 | 115 | 175 |
---|
Restructuring cost | - | - | 3 |
---|
Total operating expenses | 70 | 115 | 175 |
---|
Loss from operations | -70 | -132 | -230 |
---|
Change in fair value of common stock warrants and convertible preferred stock warrants | 56 | -75 | -6 |
---|
Interest income | - | - | 14 |
---|
Interest expense | - | - | 4 |
---|
Other income (expense), net | -0 | -0 | -0 |
---|
Interest income (expense), net | -0 | 5 | - |
---|
Total other income (expense), net | -56 | 80 | 15 |
---|
Other income (expense), net | -0 | -0 | -0 |
---|
Total other income (expense), net | -56 | 80 | 15 |
---|
Comprehensive Income (Loss), Net of Tax, Attributable to Parent | - | -52 | - |
---|
Net loss attributable to Enovix | -126 | -52 | -214 |
---|
Loss before income tax benefit | - | - | -215 |
---|
Earnings Per Share, Basic | - | -0.34 | -1.35 |
---|
Income tax benefit | - | - | -1 |
---|
Net loss | -126 | - | -214 |
---|
Earnings Per Share, Diluted | - | -0.82 | -1.38 |
---|
Net loss attributable to non-controlling interests | - | - | -0 |
---|
Net loss attributable to Enovix | -126 | -52 | -214 |
---|
Earnings Per Share, Basic | - | -0.34 | -1.35 |
---|
Earnings Per Share, Diluted | - | -0.82 | -1.38 |
---|